| |
|
|
|
|
|
|
|||
|
Blood, Vol. 111, Issue 1, 109-111, January 1, 2008
Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG) Files in this Data Supplement:
| |||||||||||||||||||||||||||||
| Copyright © 2009 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||